LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML

LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML

10.1158/1541-7786.MCR-16-0275-T

Saved in:

Bibliographic Details
Main Authors:	Zhou, Jianbiao, Chan, Zit-Liang, Bi, Chonglei, Lu, Xiao, Chong, Phyllis SY, Chooi, Jing-Yuan, Cheong, Lip-Lee, Liu, Shaw-Cheng, Ching, Ying Qing, Zhou, Yafeng, Osato, Motomi, Tan, Tuan Zea, Ng, Chin Hin, Ng, Siok-Bian, Wang, Shi, Zeng, Qi, Chng, Wee-Joo
Other Authors:	MEDICINE
Format:	Article
Language:	English
Published:	AMER ASSOC CANCER RESEARCH 2021
Subjects:	Science & Technology Life Sciences & Biomedicine Oncology Cell Biology ACUTE MYELOID-LEUKEMIA MONOCLONAL-ANTIBODIES MICRORNA BIOGENESIS REGENERATING LIVER PHOSPHATASE PRL-3 CANCER METASTASIS EXPRESSION PROTEIN TARGET
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/207398
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Similar Items

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis
by: Guo, Mingrui, et al.
Published: (2023)

PRL-3 phosphatase and cancer metastasis
by: Al-Aidaroos, A.Q.O., et al.
Published: (2014)

Engineering the First Chimeric Antibody in Targeting Intracellular PRL-3 Oncoprotein for Cancer Therapy in Mice
by: Guo, Ke, et al.
Published: (2021)

GLOBAL DISCOVERY OF DYSREGULATED PROTEIN EXPRESSION AND PHOSPHORYLATION NETWORKS IDENTIFIED LEO1 AS A KEY TARGET OF PRL-3 PHOSPHATASE IN LEUKEMOGENESIS
by: CHONG SHU YUN, PHYLLIS
Published: (2015)

Engineering the first chimeric antibody in targeting intracellular PRL-3 oncoprotein for cancer therapy in mice
by: Guo, K., et al.
Published: (2014)

In vitro and in vivo study of ABT-869 in treatment acute myeloid leukemia (AML) alone or in combination with chemotherapy or HDAC inhibitors: insight into molecular mechanism and biologic characterization
by: ZHOU JIANBIAO
Published: (2010)

NF-kappa B promotes the stem-like properties of leukemia cells by activation of LIN28B
by: Zhou, Jianbiao, et al.
Published: (2022)

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies
by: Chee, Cheng E, et al.
Published: (2023)

PRL-3 dephosphorylates p38 MAPK to promote cell survival under stress
by: Shi, Yin, et al.
Published: (2022)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
by: Park, J.E., et al.
Published: (2014)

IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma
by: Chong, Phyllis SY, et al.
Published: (2020)

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase
by: Zhou, J, et al.
Published: (2020)

Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice
by: Yanagida, M., et al.
Published: (2011)

PRL-3 suppresses c-Fos and integrin α2 expression in ovarian cancer cells
by: Liu, H., et al.
Published: (2014)

Ponatinib analogues: Virtual screening, precursor, synthesis, and approaches in the preparation of selected compounds
by: Padilla, Vince Lambert H.
Published: (2020)

PRL-3 promotes epithelial-mesenchymal transition and confers resistance to apoptosis
by: SAMANTHA QUAH YILING
Published: (2010)

NOVEL RNA-BASED CANCER VACCINE FOR AML IMMUNOTHERAPY
by: THAM GUO HONG
Published: (2024)

THE MECHANISM OF PRL-3 SIGNALLING UNDER CELLULAR STRESS
by: YE ZU
Published: (2015)

A ROLE OF PRL-3 IN AUTOPHAGY AND ITS REGULATION IN HUMAN CANCERS
by: HUANG YUHAN
Published: (2015)

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
by: Ptasinska, A., et al.
Published: (2014)

The role of non-neuronal cholinergic components in leukemogenesis
by: Sadudee Chotirat
Published: (2023)

Point mutations in the RUNX1/AML1 gene: Another actor in RUNX leukemia
by: Osato, M.
Published: (2011)

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.
by: Zhou, Jianbiao, et al.
Published: (2022)

Chromosomal aberrations and molecular changes in BCR-ABL gene in Chronic Myelogenous Leukemia (CML) patients undergoing chemotherapy
by: Soriano-Abad, Ma. Celeste S.
Published: (2010)

C/EBPβ promotes BCR-ABL-mediated myeloid expansion and leukemic stem cell exhaustion
by: Hayashi, Y., et al.
Published: (2016)

Survival of childhood leukemia in Singapore
by: Quah, T.C., et al.
Published: (2013)

Parenteral glutamine-dipeptide supplementation in acute myeloid leukemia patients receiving chemotherapy : effects on neutrophil functions, prevention of chemotherapy-induced side effects and impact on cost-effectiveness
by: Chuleegone Sornsuvit
Published: (2023)

LIPOSOMAL FORMULATION OF RATIONAL COMBINATION OF BIOACTIVE LIPIDS FOR THE TREATMENT OF LEUKEMIA
by: TAN KUAN BOONE
Published: (2013)

X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery
by: Zhou, J., et al.
Published: (2021)

Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation-an uncommon presentation in adults
by: Krishnan, S., et al.
Published: (2016)

Cytogenetic profile of acute myeloid leukaemia (AML) patients in Singapore General Hospital (SGH)
by: Ho, Charmaine Jia Yi
Published: (2024)

SRRM2 organizes splicing condensates to regulate alternative splicing
by: Xu, Shaohai, et al.
Published: (2023)

Autologous bone marrow transplantation in a child with acute promyelocytic leukemia in second remission
by: Quah, T.C., et al.
Published: (2013)

In vivo efficacy of a novel liposomal formulation of safingol in the treatment of acute myeloid leukemia
by: Tan, K.-B., et al.
Published: (2014)

Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemia
by: Chong, Phyllis SY, et al.
Published: (2020)

Diagnostic significance of Philadelphia chromosome BCR-ABL fusion gene detected by GTG-banding and reverse-transcription polymerase chain reaction (RT-PCR) in Filipino patients with chronic myelogenous leukemia (CML)
by: Amarillo, Ferdinand F., et al.
Published: (2003)

CORE BINDING FACTOR FUSION DOWNREGULATION OF ADAR2 RNA EDITING CONTRIBUTES TO AML LEUKEMOGENESIS
by: GUO MINGRUI
Published: (2022)

PCBP1 Suppresses the Translation of Metastasis-Associated PRL-3 Phosphatase
by: Wang, Haihe, et al.
Published: (2021)

Dual mutations in the AML1 and FLT 3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype
by: Matsuno, N., et al.
Published: (2011)

Establishment of a Detecting Procedure and Analysis of CEBPA-TAD Genetic Mutation in Vietnamese Acute Myeloid Leukemia Patients
by: Bui, Thuy Huong, et al.
Published: (2018)